The Night Watch: Summit Joins Visx in Cutting Prices, but Both Rise
Peer pressure was always a major concern of high school guidance counselors, who felt it could make teenagers jump off the Brooklyn Bridge.
Tonight, peer pressure caught up with Summit Technology (BEAM). No, it didn't take a fateful leap, but it did follow the lead of a rival vision-correction outfit and lower the royalty collected on laser surgery to $100 from $250. Yesterday, Visx (VISX) did the same thing in hopes that lower prices will expand market share. Last night, Visx got killed on the news that it would lower its royalty fees. Investors and analysts screamed that it would kill a vital source of revenue for the company. Today, both eye laser makers were cut by Lehman Brothers analyst David Gruber, who was pretty unhappy. How unhappy? Very. He slashed the Visx price target to 14 from 60 and dropped Summit's price target to 18 from 25. During the day, both stocks fell on the downgrade. Visx dropped 5 9/16, or 25%, to 16 5/16, while Summit fell 4 1/4, or 35%, to 7 13/16. Things were different this evening. Investors have seen the light and flocked to the pair. Visx rose 1 1/4 to 17 9/16 on 401,000 shares, while Summit rose 1 9/32 to 9 1/32 on 599,000 shares.Late in the day session, Cisco (CSCO) came on stronger than a showroom salesman during the opening minutes of a "Toyotathon" sales event. The company pushed its 52-week-high deeper and deeper into record territory on news that it would be working with Tekelec (TKLC) to help fuse networking gear with existing telephony. The hope is that Cisco and other competitors, such as Lucent (LU) and Nortel (NT), will be able to increase productivity and performance by using digital technology. After the news hit the Street, traders promptly swept into both companies. Cisco and Tekelec each closed at new records, with Tekelec ending up 6 31/32, or 19%, to 43 3/8. Cisco rode a wild momentum swing in the final hour to conclude plus 14 11/16, or 12%, to 138 5/8. It traded 17.9 million shares from 3 p.m. to 4 p.m. EST, 43% of its daylong trading volume. Some of this momentum carried over into the postclose session and then quickly waned. At last check Cisco was off 1 9/16 to 137 on 250,000 shares, good enough to land it at the No. 6 most-active spot. Orders in the networking giant were a fairly healthy 1,048, but liquidity was a problem, despite all the orders. Buy orders dominated sellers by a 2-to-1 margin, but the gap between the two was wide. Most sellers lurk north of 139, while buyers hope to get lucky below 135.
priceline.com (PCLN) investors named their own stock price after hours. The e-tailer rose 5 to 56 3/8 on 87,000 shares. After the bell, priceline.com announced that Heidi Miller, former Citigroup (C) CFO, would become the company's new CFO. Investors acted like the company found a replacement for William Shatner, adding more to its day session gain of 1 3/4, or 4%, to 51 7/8. Elsewhere on the large-cap front, Qualcomm (QCOM) took a cold shower after its hot day, while Chemdex (CMDX) joined the frigid fray. Qualcomm was last off 3 13/16 to 143 1/16 on 123,000 shares on Island, giving back some of its gain of 16 5/16, or 13%, to 146 7/8. During the day, Super Q was one of Nasdaq's biggest point gainers. Chemdex wasn't one of the Nasdaq's biggest point gainers. It was the Nasdaq's biggest point gainer, gaining 45 1/4, or 29%, to 200 1/2, on news that it would be rechristening itself Ventro and joining the B2B fray. Tonight, the heat subsided and the company soon to be known as Ventro dropped 3 7/16 to 197 1/16 on 41,000 shares, reversing gains from earlier in the postclose session. Curious about Ventro? Adam Lashinsky's piece from earlier today is the perfect place to get more in-depth information on the Chemdex crossover.
John McCain's got some momentum -- last night's victory in Michigan's not-entirely-Republican primary proved that. But biotechs have more momentum than any presidential candidate running. With sector interest at a fever pitch, investors are scraping to find undiscovered candidates that they hope will run. Tonight's investors threw their interest into a pair of foreign micro-cap biotechs. The first, at the top spot on Island's most-actives list, was Xenova Group (XNVA), a U.K.-based cancer fighter. The company rose 2 5/16 to 6 1/2 on 1.25 million shares, a recovery from today's day session fall of 9/16 to 4 3/16. On Friday, two trading days ago, interest in the company hit a fever pitch and shares closed up almost 5 points to 7 5/8. Since then, it has eased significantly. The second baby biotech was down at the No. 9 spot. Senetek (SNTKY), another British biotech, eased 1/4 to 3 1/2 on 220,000 shares. Unlike Xenova, this Brit hopped during the day session, gaining 1 1/16, or 42%, to 3 5/8.
| 10 most active stocks on Island ECN (8 p.m. EST) | |||
| Company | Price | Change | Session Volume |
| Xenova Group plc (XNVA) | 6 1/2 | +2 5/16 | 1,203,764 |
| T&W Financial (TWFC) | 1 | +3/32 | 1,088,624 |
| Summit Technology (BEAM) | 9 1/32 | +1 9/32 | 489,418 |
| Dynamic Oil & Gas (DYOLF) | 1 5/32 | +1/16 | 439,874 |
| Visx (VISX) | 17 9/16 | +1 1/4 | 325,874 |
| Cisco (CSCO) | 137 | -1 9/16 | 238,180 |
| Zmax (ZMAX) | 6 27/32 | -27/32 | 235,932 |
| Imaging Technologies (ITEC) | 1 145/256 | +1/128 | 219,700 |
| Senetek plc (SNTKY) | 3 1/2 | -1/4 | 189,040 |
| National Home Centers (NHCI) | 1 1/16 | n/a | 149,854 |
| 10 most active stocks on MarketXT (8 p.m. EST) | |||
| Company | Price | Change | Session Volume |
| Visx (VISX) | 17 5/8 | +1 5/16 | 8,340 |
| SBC Communications (SBC) | 35 3/8 | -3/8 | 7,200 |
| Global Crossing (GBLX) | 48 1/2 | +3/16 | 7,196 |
| Cisco (CSCO) | 136 1/2 | -2 1/8 | 5,450 |
| Qualcomm (QCOM) | 142 1/16 | -4 13/16 | 5,148 |
| Summit Technologies (BEAM) | 9 3/16 | +1 3/8 | 4,700 |
| Lucent (LU) | 53 | +1/8 | 4,600 |
| America Online (AOL) | 58 3/4 | +7/16 | 2,400 |
| Whittman-Hart Industries (WHIT) | 38 1/2 | +7/16 | 2,000 |
| Superconductor Technologies (SCON) | 48 | +7/8 | 2,000 |
TheStreet Premium Services For Personal Service: 877-471-2967
Jim Cramer's Action Alerts PLUS:
Trade right alongside a Wall Street pro — enjoy access to his Charitable Trust portfolio and be sent trade alerts BEFORE he makes a move. Learn MoreETF Profits:
Get money-making ideas from the hottest investment vehicle on the planet. Our experts show you how to play various ETF sectors to help pump-up your portfolio. Learn MoreOptionsProfits:
Get 50+ trade ideas a week from the industry's top options experts. Plus — exclusive commentary on market trends and essential trading tools. Learn MoreReal Money:
Our team of professional Wall Street Pros — including Jim Cramer, Doug Kass, and Nicholas Vardy — delivers intelligent analysis, timely trade ideas, and colorful commentary. Learn MoreStocks Under $10:
Break into the market with small- and mid-cap stocks... all $10 or less! David Peltier tells you exactly which low-priced stocks he's buying and selling. Learn MoreTo begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
blog comments powered by Disqus
| Dow Jones | S&P 500 | NASDAQ | 10-Year Note | |
|---|---|---|---|---|
| 12,890.46 | 1,351.95 | 2,927.23 | 20.47 |
Oil *
118.75
|
|
UP
6.51 |
UP
1.99 |
UP
11.37 |
UP
0.72 |
10 Yr
2.05%
SPDR Gold
168.02
|
|
+0.05%
|
+0.15%
|
+0.39%
|
+3.65%
|
Data delayed 20 minutes |

Connect with TheStreet